Drug Shortage Report for JAMP-OXCARBAZEPINE

Last updated on 2021-04-07 History
Report ID 64268
Drug Identification Number 02440717
Brand name JAMP-OXCARBAZEPINE
Common or Proper name OXCARBAZEPINE
Company Name JAMP PHARMA CORPORATION
Market Status CANCELLED POST MARKET
Active Ingredient(s) OXCARBAZEPINE
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-10-12
Estimated end date 2022-12-30
Actual end date
Shortage status Actual shortage
Updated date 2021-04-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2021-04-07 French Compare
v11 2021-04-07 English Compare
v10 2020-06-19 French Compare
v9 2020-06-19 English Compare
v8 2020-02-18 French Compare
v7 2020-02-18 English Compare
v6 2019-04-18 French Compare
v5 2019-04-18 English Compare
v4 2018-12-19 French Compare
v3 2018-12-19 English Compare
v2 2018-10-15 French Compare
v1 2018-10-15 English Compare

Showing 1 to 12 of 12